Product Information
EMTRIVA 200 MG CAPSULE is a brand product labeled by Gilead Sciences, Inc., priced at $17.4459 per EA under NDC 61958060101. Its NADAC has been published 519 times since Nov 28, 2013.
Strength
200 mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958060101
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINEApproval Type
New Drug (NDA)
FDA Application
NDA021500On Market Since
7/2/2003
Pharmacological Classes
Price Statistics
The NADAC for EMTRIVA 200 MG CAPSULE has been published 519 times since Nov 28, 2013, and over the history we have for it it has risen 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.4459 per EA |
|---|---|
| All-time high | $17.7567 (Jan 11, 2017) |
| All-time low | $15.3525 (Dec 18, 2013) |
| 52-week high | $17.4459 |
| 52-week low | $17.4267 |
| Median price | $17.3547 |
| Average price | $17.1672 |
| Largest weekly change | +6.9% (Apr 8, 2015) |
| Weeks tracked | 519 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the EMTRICITABINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EMTRIVA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EMTRIVA 200 MG CAPSULE, manufactured by Gilead Sciences, Inc., is $17.4459 per EA (NDC 61958060101), effective Jun 24, 2026.
How has the price of EMTRIVA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EMTRIVA 200 MG CAPSULE has risen 13.3%. It has been tracked across 519 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMTRIVA 200 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EMTRIVA 200 MG CAPSULE has ranged from a low of $15.3525 (Dec 18, 2013) to a high of $17.7567 (Jan 11, 2017), with a median of $17.3547 per EA.
Are there cheaper alternatives to EMTRIVA 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EMTRIVA 200 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures EMTRIVA 200 MG CAPSULE?
EMTRIVA 200 MG CAPSULE (NDC 61958060101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification